Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2026-06-16 @ 4:02 AM
Study NCT ID:
NCT04901702
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2021-04-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Sponsor:
St. Jude Children's Research Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Solid Tumor | View |
| None | Recurrent Ewing Sarcoma | View |
| None | Recurrent Hepatoblastoma | View |
| None | Recurrent Malignant Germ Cell Tumor | View |
| None | Recurrent Malignant Solid Neoplasm | View |
| None | Recurrent Neuroblastoma | View |
| None | Recurrent Osteosarcoma | View |
| None | Recurrent Peripheral Primitive Neuroectodermal Tumor | View |
| None | Recurrent Rhabdoid Tumor | View |
| None | Recurrent Rhabdomyosarcoma | View |
| None | Recurrent Soft Tissue Sarcoma | View |
| None | Recurrent Wilms Tumor | View |
| None | Refractory Ewing Sarcoma | View |
| None | Refractory Hepatoblastoma | View |
| None | Refractory Malignant Germ Cell Tumor | View |
| None | Refractory Malignant Solid Neoplasm | View |
| None | Refractory Neuroblastoma | View |
| None | Refractory Osteosarcoma | View |
| None | Refractory Peripheral Primitive Neuroectodermal Tumor | View |
| None | Refractory Rhabdoid Tumor | View |
| None | Refractory Rhabdomyosarcoma | View |
| None | Refractory Soft Tissue Sarcoma | View |